{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:38:04Z","timestamp":1788950284146,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41401-025-01671-y","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:44:06Z","timestamp":1762152246000},"page":"625-635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The mGluR2\/3 agonist xanthurenic acid improves memory, attention, and synaptic deficits by modulating glutamate release in Alzheimer\u2019s disease model"],"prefix":"10.1038","volume":"47","author":[{"given":"Kyonghwan","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Yeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hwa","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/biomedicines10040849","volume":"10","author":"D Martos","year":"2022","unstructured":"Martos D, Tuka B, Tanaka M, V\u00e9csei L, Telegdy G. Memory enhancement with kynurenic acid and its mechanisms in neurotransmission. Biomedicines. 2022;10:849.","journal-title":"Biomedicines"},{"key":"1671_CR2","doi-asserted-by":"crossref","unstructured":"Hanson LR, Fine JM, Svitak AL, Faltesek KA. Intranasal administration of CNS therapeutics to awake mice. J Vis Exp. 2013;74:4440.","DOI":"10.3791\/4440-v"},{"key":"1671_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72098-0","volume":"10","author":"M Luvuno","year":"2020","unstructured":"Luvuno M, Khathi A, Mabandla MV. The effects of exercise treatment on learning and memory ability, and cognitive performance in diet-induced prediabetes animals. Sci Rep. 2020;10:15048.","journal-title":"Sci Rep."},{"key":"1671_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3758\/s13428-020-01452-x","volume":"53","author":"M Cleal","year":"2021","unstructured":"Cleal M, Fontana BD, Ranson DC, McBride SD, Swinny JD, Redhead ES, et al. The free-movement pattern y-maze: a cross-species measure of working memory and executive function. Behav Res Methods. 2021;53:536\u201357.","journal-title":"Behav Res Methods"},{"key":"1671_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47\u201360.","journal-title":"J Neurosci Methods"},{"key":"1671_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep24493","volume":"6","author":"H Badshah","year":"2016","unstructured":"Badshah H, Ali T, Kim MO. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4\/NF\u03baB signaling pathway. Sci Rep. 2016;6:1\u201313.","journal-title":"Sci Rep."},{"key":"1671_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12929-023-00961-z","volume":"30","author":"JS Park","year":"2023","unstructured":"Park JS, Choe K, Lee HJ, Park TJ, Kim MO. Neuroprotective effects of osmotin in Parkinson\u2019s disease-associated pathology via the AdipoR1\/MAPK\/AMPK\/mTOR signaling pathways. J Biomed Sci. 2023;30:66.","journal-title":"J Biomed Sci"},{"key":"1671_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuropharm.2013.02.006","volume":"70","author":"C Klein","year":"2013","unstructured":"Klein C, Patte-Mensah C, Taleb O, Bourguignon J-J, Schmitt M, Bihel F, et al. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Neuropharmacology. 2013;70:254\u201360.","journal-title":"Neuropharmacology"},{"key":"1671_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep40753","volume":"7","author":"FU Amin","year":"2017","unstructured":"Amin FU, Shah SA, Kim MO. Vanillic acid attenuates A\u03b21\u201342-induced oxidative stress and cognitive impairment in mice. Sci Rep. 2017;7:40753.","journal-title":"Sci Rep."},{"key":"1671_CR10","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s12035-016-9795-4","volume":"54","author":"A Ahmad","year":"2017","unstructured":"Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO, et al. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive\/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Mol Neurobiol. 2017;54:2269\u201385.","journal-title":"Mol Neurobiol"},{"key":"1671_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuint.2015.07.001","volume":"90","author":"F Ullah","year":"2015","unstructured":"Ullah F, Ali T, Ullah N, Kim MO. Caffeine prevents D-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. Neurochem Int. 2015;90:114\u201324.","journal-title":"Neurochem Int."},{"key":"1671_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116888","volume":"239","author":"J Ali","year":"2019","unstructured":"Ali J, Khan AU, Shah FA, Ali H, Islam SU, Kim YS, et al. Mucoprotective effects of Saikosaponin-A in 5-Fluorouracil-induced intestinal mucositis in mice model. Life Sci. 2019;239:116888.","journal-title":"Life Sci"},{"key":"1671_CR13","doi-asserted-by":"crossref","unstructured":"Habig WH, Jakoby WB. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 1981;77:398\u2013405.","DOI":"10.1016\/S0076-6879(81)77053-8"},{"key":"1671_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0278-6915(01)00020-5","volume":"39","author":"M Arts","year":"2001","unstructured":"Arts M, Haenen G, Voss HP, Bast A. Masking of antioxidant capacity by the interaction of flavonoids with protein. Food Chem Toxicol. 2001;39:787\u201391.","journal-title":"Food Chem Toxicol."},{"key":"1671_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0003-9861(67)90273-1","volume":"118","author":"HG Utley","year":"1967","unstructured":"Utley HG, Bernheim F, Hochstein P. Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys. 1967;118:29\u201332.","journal-title":"Arch Biochem Biophys"},{"key":"1671_CR16","doi-asserted-by":"publisher","first-page":"e48553","DOI":"10.1371\/journal.pone.0048553","volume":"7","author":"O Taleb","year":"2012","unstructured":"Taleb O, Maammar M, Brumaru D, Bourguignon J-J, Schmitt M, Klein C, et al. Xanthurenic acid binds to neuronal G-protein-coupled receptors that secondarily activate cationic channels in the cell line NCB-20. PLoS One. 2012;7:e48553.","journal-title":"PLoS One"},{"key":"1671_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroscience.2016.05.006","volume":"329","author":"G Roussel","year":"2016","unstructured":"Roussel G, Bessede A, Klein C, Maitre M, Mensah-Nyagan AG. Xanthurenic acid is localized in neurons in the central nervous system. Neuroscience. 2016;329:226\u201338.","journal-title":"Neuroscience"},{"key":"1671_CR18","doi-asserted-by":"crossref","unstructured":"Choe K, Bakker L, van den Hove DL, Eussen SJ, Kenis G, Ramakers IH, et al. Kynurenine pathway dysregulation in cognitive impairment and dementia: a systematic review and meta-analysis. GeroScience. 2025:1\u201335.","DOI":"10.1007\/s11357-025-01636-3"},{"key":"1671_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-020-00741-z","volume":"13","author":"L Whiley","year":"2021","unstructured":"Whiley L, Chappell KE, D\u2019hondt E, Lewis MR, Jim\u00e9nez B, Snowden SG, et al. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:20.","journal-title":"Alzheimers Res Ther"},{"key":"1671_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cei.12092","volume":"173","author":"D Theofylaktopoulou","year":"2013","unstructured":"Theofylaktopoulou D, Midttun \u00d8, Ulvik A, Ueland P, Tell G, Vollset S, et al. A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin Exp Immunol. 2013;173:121\u201330.","journal-title":"Clin Exp Immunol"},{"key":"1671_CR21","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","volume":"31","author":"S Li","year":"2011","unstructured":"Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM, Selkoe DJ. Soluble A\u03b2 oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci. 2011;31:6627\u201338.","journal-title":"J Neurosci"},{"key":"1671_CR22","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/jnr.22392","volume":"88","author":"R Clare","year":"2010","unstructured":"Clare R, King VG, Wirenfeldt M, Vinters HV. Synapse loss in dementias. J Neurosci Res. 2010;88:2083\u201390.","journal-title":"J Neurosci Res"},{"key":"1671_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101208","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH. Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev. 2021;65:101208.","journal-title":"Ageing Res Rev"},{"key":"1671_CR24","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid \u03b2 associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA. 2009;106:4012\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1671_CR25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4103\/1673-5374.184481","volume":"11","author":"Y Vyas","year":"2016","unstructured":"Vyas Y, Montgomery JM. The role of postsynaptic density proteins in neural degeneration and regeneration. Neural Regen Res. 2016;11:906\u20137.","journal-title":"Neural Regen Res"},{"key":"1671_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.","journal-title":"Signal Transduct Target Ther"},{"key":"1671_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphys.2012.00008","volume":"3","author":"B Dislich","year":"2012","unstructured":"Dislich B, Lichtenthaler SF. The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer\u2019s disease and beyond. Front Physiol. 2012;3:8.","journal-title":"Front Physiol"},{"key":"1671_CR28","doi-asserted-by":"publisher","first-page":"27737","DOI":"10.1074\/jbc.M110.117960","volume":"285","author":"B Liang","year":"2010","unstructured":"Liang B, Duan B-Y, Zhou X-P, Gong J-X, Luo Z-G. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Biol Chem. 2010;285:27737\u201344.","journal-title":"J Biol Chem"},{"key":"1671_CR29","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.3390\/nu15234986","volume":"15","author":"J Ali","year":"2023","unstructured":"Ali J, Khan A, Park JS, Tahir M, Ahmad W, Choe K, et al. Neuroprotective effects of N-methyl-(2S, 4R)-trans-4-hydroxy-L-proline (NMP) against amyloid-\u03b2-induced Alzheimer\u2019s disease mouse model. Nutrients. 2023;15:4986.","journal-title":"Nutrients"},{"key":"1671_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jep.2019.02.046","volume":"237","author":"M Xu","year":"2019","unstructured":"Xu M, Yan T, Fan K, Wang M, Qi Y, Xiao F, et al. Polysaccharide of Schisandra chinensis fructus ameliorates cognitive decline in a mouse model of Alzheimer\u2019s disease. J Ethnopharmacol. 2019;237:354\u201365.","journal-title":"J Ethnopharmacol"},{"key":"1671_CR31","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1021\/acs.jpcb.2c01769","volume":"126","author":"HL Nguyen","year":"2022","unstructured":"Nguyen HL, Linh HQ, Krupa P, La Penna G, Li MS. Amyloid \u03b2 dodecamer disrupts the neuronal membrane more strongly than the mature fibril: understanding the role of oligomers in neurotoxicity. J Phys Chem B. 2022;126:3659\u201372.","journal-title":"J Phys Chem B"},{"key":"1671_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1471-4159.2008.05347.x","volume":"106","author":"PB Shelat","year":"2008","unstructured":"Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, et al. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem. 2008;106:45\u201355.","journal-title":"J Neurochem"},{"key":"1671_CR33","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","volume":"15","author":"IJ Reynolds","year":"1995","unstructured":"Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci. 1995;15:3318\u201327.","journal-title":"J Neurosci"},{"key":"1671_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye XY, Xie Y, Xie T. Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev. 2022;77:101619.","journal-title":"Ageing Res Rev."},{"key":"1671_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.55782\/ane-2004-1494","volume":"64","author":"HG Lee","year":"2004","unstructured":"Lee HG, Zhu X, O\u2019Neill MJ, Webber K, Casadesus G, Marlatt M, et al. The role of metabotropic glutamate receptors in Alzheimer\u2019s disease. Acta Neurobiol Exp. 2004;64:89\u201398.","journal-title":"Acta Neurobiol Exp"},{"key":"1671_CR36","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","volume":"27","author":"C Corti","year":"2007","unstructured":"Corti C, Battaglia G, Molinaro G, Riozzi B, Pittaluga A, Corsi M, et al. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection. J Neurosci. 2007;27:8297\u2013308.","journal-title":"J Neurosci"},{"key":"1671_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2012.03.009","volume":"66","author":"CS Copeland","year":"2013","unstructured":"Copeland CS, Neale SA, Salt TE. Actions of xanthurenic acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Neuropharmacology. 2013;66:133\u201342.","journal-title":"Neuropharmacology"},{"key":"1671_CR38","doi-asserted-by":"publisher","first-page":"6974","DOI":"10.3390\/ijms22136974","volume":"22","author":"O Taleb","year":"2021","unstructured":"Taleb O, Maammar M, Klein C, Maitre M, Mensah-Nyagan AG. A role for xanthurenic acid in the control of brain dopaminergic activity. Int J Mol Sci. 2021;22:6974.","journal-title":"Int J Mol Sci"},{"key":"1671_CR39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/npp.2013.4","volume":"38","author":"S Neale","year":"2013","unstructured":"Neale S, Copeland C, Uebele V, Thomson F, Salt T. Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors. Neuropsychopharmacology. 2013;38:1060\u20137.","journal-title":"Neuropsychopharmacology"},{"key":"1671_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/cercor\/bhx005","volume":"28","author":"LE Jin","year":"2018","unstructured":"Jin LE, Wang M, Galvin VC, Lightbourne TC, Conn PJ, Arnsten AF, et al. mGluR2 versus mGluR3 metabotropic glutamate receptors in primate dorsolateral prefrontal cortex: postsynaptic mGluR3 strengthen working memory networks. Cereb Cortex. 2018;28:974\u201387.","journal-title":"Cereb Cortex"},{"key":"1671_CR41","doi-asserted-by":"crossref","unstructured":"Ennis M, Hamilton K, Hayar A. Neurochemistry of the main olfactory system. In: Handbook of neurochemistry and molecular neurobiology. New York: Springer; 2007 p 137\u2013204.","DOI":"10.1007\/978-0-387-30374-1_6"},{"key":"1671_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-S3-S5","volume":"9","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008;9:S5.","journal-title":"BMC Neurosci"},{"key":"1671_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fnmol.2018.00255","volume":"11","author":"H Wang","year":"2018","unstructured":"Wang H, Xu J, Lazarovici P, Quirion R, Zheng W. cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia. Front Mol Neurosci. 2018;11:255.","journal-title":"Front Mol Neurosci"},{"key":"1671_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108275","volume":"239","author":"SH Li","year":"2022","unstructured":"Li SH, Abd-Elrahman KS, Ferguson SS. Targeting mGluR2\/3 for treatment of neurodegenerative and neuropsychiatric diseases. Pharmacol Ther. 2022;239:108275.","journal-title":"Pharmacol Ther"},{"key":"1671_CR45","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/mp.2014.87","volume":"19","author":"S Kim","year":"2014","unstructured":"Kim S, Steele J, Lee S, Clemenson G, Carter T, Treuner K, et al. Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer A\u03b2 oligomer mouse. Mol Psychiatry. 2014;19:1235\u201342.","journal-title":"Mol Psychiatry"},{"key":"1671_CR46","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1523\/JNEUROSCI.4717-09.2010","volume":"30","author":"SH Kim","year":"2010","unstructured":"Kim SH, Fraser PE, Westaway D, George-Hyslop PHS, Ehrlich ME, Gandy S, et al. Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer\u2019s amyloid \u03b242 from isolated intact nerve terminals. J Neurosci. 2010;30:3870\u20135.","journal-title":"J Neurosci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01671-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01671-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01671-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:02:34Z","timestamp":1771959754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01671-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01671-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author Myeong Ok Kim was employed by the company Alz-Dementia Korea Co. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}